Cargando…
Uncovering Beta-Lactam Susceptibility Patterns in Clinical Isolates of Mycobacterium tuberculosis through Whole-Genome Sequencing
The increasing threat of drug resistance and a stagnated pipeline of novel therapeutics endanger the eradication of tuberculosis. Beta-lactams constitute promising additions to the current therapeutic arsenal and two carbapenems are included in group C of medicines recommended by the WHO for use in...
Autores principales: | Olivença, Francisco, Nunes, Alexandra, Macedo, Rita, Pires, David, Silveiro, Cátia, Anes, Elsa, Miragaia, Maria, Gomes, João Paulo, Catalão, Maria João |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431576/ https://www.ncbi.nlm.nih.gov/pubmed/35695524 http://dx.doi.org/10.1128/spectrum.00674-22 |
Ejemplares similares
-
CRISPRi-mediated characterization of novel anti-tuberculosis targets: Mycobacterial peptidoglycan modifications promote beta-lactam resistance and intracellular survival
por: Silveiro, Cátia, et al.
Publicado: (2023) -
Identification of drivers of mycobacterial resistance to peptidoglycan synthesis inhibitors
por: Olivença, Francisco, et al.
Publicado: (2022) -
Modulation of Cystatin F in Human Macrophages Impacts Cathepsin-Driven Killing of Multidrug-Resistant Mycobacterium tuberculosis
por: Mandal, Manoj, et al.
Publicado: (2023) -
Liposomal Delivery of Saquinavir to Macrophages Overcomes Cathepsin Blockade by Mycobacterium tuberculosis and Helps Control the Phagosomal Replicative Niches
por: Pires, David, et al.
Publicado: (2023) -
Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant Mycobacterium tuberculosis
por: Pires, David, et al.
Publicado: (2023)